Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.
US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...
The state has for several years been moving toward competitive integrated employment, in which people with disabilities work ...
There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.
India is trying to pry open the doors of the world’s biggest app stores, setting up a likely clash with Apple Inc. and ...
The transaction would help create a defense tech company with a broader portfolio of space platforms combined with ...
In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...
Eli Lilly has announced plans to acquire Scorpion Therapeutics’ PI3Kα inhibitor program. Credit: Michael Vi via Shutterstock. Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor ...
Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself ...
Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...
Compared with the same month last year, the European Union imported significantly more pharmaceutical products from Russia in ...
12d
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback